10 Tips to Get You Through Cold and Flu Season

10 Tips to Get You Through Cold and Flu Season

It’s that time of year when everyone starts to get sick and pass around their cold and flu germs. Having a chronic illness means that your immune system is already compromised, which makes picking up other people’s winter illnesses harder to avoid. However, you don’t have to lock yourself away…

ALS End-stage Brain Damage Isn’t Limited to Motor Neurons, Study Finds

Patients with amyotrophic lateral sclerosis (ALS) who have progressed to a stage in which they’ve lost all voluntary movements, including the ability to communicate, have damage in numerous brain regions and isn’t limited to motor neurons. The study, “Clinicopathological characteristics of patients with amyotrophic lateral sclerosis resulting in…

ALS Ice Bucket Challenge: Who Is Anthony Carbajal?

In the summer of 2014, the ALS Ice Bucket Challenge became a major Internet sensation as both entertainment and as a way of raising money to fight amyotrophic lateral sclerosis (ALS). Like any good viral story, the challenge quickly spread all over the world. You’ve heard of the challenge, but…

Researchers May Have Solved ALS Molecular Misfolding Mystery

Researchers have identified a factor that prevents SOD1 — a protein causing amyotrophic lateral sclerosis (ALS) in a proportion of patients — from misfolding. The finding may advance the development of new drug therapies to stop or slow progression of the disease. The study, “Endogenous macrophage migration inhibitory factor reduces the…

Simple Reflexology: There’s More to Feeling Good

Simple Reflexology Techniques Reflexology is an ancient practice passed down through the ages. Proof of the practice may date back to pre-dynastic China 3000 BC. The Incas and Native Americans may have introduced reflexology to South and North America. What is reflexology? It is a homeopathic massage technique designed to relieve pain. Reflexology…

Masitinib Marketing Application for ALS Accepted by European Medicines Agency

AB Science recently announced that the European Medicines Agency (EMA) has accepted a conditional marketing authorization application for the tyrosine kinase inhibitor masitinib to treat amyotrophic lateral sclerosis (ALS). AB Science develops protein kinase inhibitors (PKIs), a class of targeted proteins that are key for signaling pathways within cells. It has been shown that blocking…